发明名称 EDIBLE COMPOSITION
摘要 Foods or meals high in available carbohydrate such as sucrose or starch increase postprandial blood glucose concentrations. According to Node et al. (Cardiovascular diabetology, 8, 23 (2009)), repeated high post-prandial plasma glucose "spikes" are associated with an increased risk of developing type II diabetes. Unregulated glycemic excursions are undesirable, and any reduction or "blunting" of the post-prandial glucose concentration in blood is potentially beneficial. This invention relates to an edible composition for delay of intestinal glucose uptake through synergistic inhibition of both active sodium glucose co-transporter 1 (SGLT1 ) and passive glucose transporter 2 (GLUT2) leading to flattening or blunting of the post-prandial glucose peak. Thus in a first aspect of the invention, an edible composition provided in the form of a single serving of one or more unit dosages comprising a combination of 2 to 200 mg of at least one homoisoflavonoid and 20 to 2000 mg of at least one flavonoid monoglucoside, and salts thereof.
申请公布号 WO2017036926(A1) 申请公布日期 2017.03.09
申请号 WO2016EP70118 申请日期 2016.08.25
申请人 UNILEVER PLC;UNILEVER N.V.;CONOPCO, INC., D/B/A UNILEVER 发明人 FOWLER, Mark, Ian;WANG, Huijun
分类号 A23L33/105 主分类号 A23L33/105
代理机构 代理人
主权项
地址